Ross Fubini
CIK 1868610 · View on SEC EDGAR ↗
First SEC filing: June 15, 2026 · Latest: June 15, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 11, 2026 | DNA | A | 25,000 | — | — | 25,000 Direct | — | Acquired | (price as of 2026-08-21) |
| June 12, 2025 | DNA | A | 34,375 | — | — | 34,375 Direct | — | Acquired | (price as of 2026-08-21) |
| June 11, 2025 | DNA | M | 10,822 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| June 11, 2025 | DNA | M | 10,822 | — | — | 10,822 Direct | — | Acquired | (price as of 2026-08-21) |
| June 13, 2024 | DNA | A | 571,428 | — | — | 571,428 Direct | — | Acquired | (price as of 2026-08-21) |
| June 13, 2024 | DNA | A | 432,900 | — | — | 432,900 Direct | — | Acquired | (price as of 2026-08-21) |
| June 13, 2024 | DNA | A | 1,111,111 | — | — | 1,111,111 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 11, 2026 | DNA | Restricted Stock Units | Class A Common Stock (25,000) | — | — | 25,000 | Acquired |
| June 12, 2025 | DNA | Stock Option | Class A Common Stock (34,375) | $9.29 | June 12, 2035 | 34,375 | Acquired |
| June 11, 2025 | DNA | Restricted Stock Units | Class A Common Stock (10,822) | — | — | 10,822 | Disposed |
| June 13, 2024 | DNA | Stock Option | Class A Common Stock | $0.46 | June 13, 2034 | 571,428 | Acquired |
| June 13, 2024 | DNA | Restricted Stock Units | Class A Common Stock (432,900) | — | — | 432,900 | Acquired |
| June 13, 2024 | DNA | Stock Option | Class A Common Stock | $0.46 | June 13, 2034 | 1,111,111 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).